Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Insmed Inc (INSM)  
$101.89 3.71 (3.78%) as of 4:30 Mon 7/14


Download
   
Exchange: Nasdaq Small Cap
Security Type: Common
Shares Out: 207,360,000
Market Cap: 21.13(B)
Last Volume: 501,923 Avg Vol: 497,908
52 Week Range: $64.81 - $105.9
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    NASDAQ COMPOSITE     NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    : 8.3
Insider 6 Months    : 8.3
Insider 3/6 Months : 16.9
Guru Rank Number :  216
Guru Rank Value     : 7
Guru Occurances    : 2

 

            6 Months   1 Year   2 Year  
 
Company Profile   Insmed is a biopharmaceutical company. Co.'s commercial product, ARIKAYCE, is approved in the U.S. for the treatment of Mycobacterium avium complex lung disease and in Europe for the treatment of nontuberculous mycobacterial lung infections. Co.'s pipelines include: brensocatib, an oral reversible inhibitor of dipeptidyl peptidase 1 for the treatment of patients with bronchiectasis, cystic fibrosis and other neutrophil-mediated diseases; and treprostinil palmitil inhalation powder, an inhaled formulation of the treprostinil prodrug treprostinil palmitil for pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 3,025 3,025 3,025 3,025
Total Buy Value $201,695 $201,695 $201,695 $201,695
Total People Bought 1 1 1 1
Total Buy Transactions 2 2 2 2
Total Shares Sold 679,026 1,277,740 1,774,286 2,657,015
Total Sell Value $60,332,649 $107,713,270 $143,072,300 $179,472,384
Total People Sold 7 8 8 8
Total Sell Transactions 40 70 105 145
End Date 2025-04-13 2025-01-10 2024-07-12 2023-07-13

   
Records found: 595
  Page 1 of 24  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Bonstein Sara Chief Financial Officer   •       –      –    2025-07-07 4 AS $95.66 $5,537,460 D/D (57,764) 84,017 1%     
   Bonstein Sara Chief Financial Officer   •       –      –    2025-07-07 4 OE $19.74 $1,216,773 D/D 47,888 141,781     -
   Lewis William Chair and CEO   •       •      –    2025-07-01 4 AS $97.73 $671,612 I/I (6,830) 233,924 1%     
   Lewis William Chair and CEO   •       •      –    2025-07-01 4 OE $10.85 $74,106 I/I 6,830 240,754     -
   Bonstein Sara Chief Financial Officer   •       –      –    2025-06-23 4 AS $101.71 $5,879,089 D/D (57,765) 93,536 -7%     
   Bonstein Sara Chief Financial Officer   •       –      –    2025-06-23 4 OE $18.95 $917,479 D/D 47,889 151,301     -
   Lewis William Chair and CEO   •       •      –    2025-06-16 4 AS $98.50 $13,031,681 I/I (129,805) 233,924 -3%     
   Lewis William Chair and CEO   •       •      –    2025-06-16 4 OE $10.85 $1,408,384 I/I 129,805 363,729     -
   Lewis William Chair and CEO   •       •      –    2025-06-16 4 AS $98.51 $522,063 D/D (5,204) 303,554 -3%     
   Adsett Roger Chief Operating Officer   •       –      –    2025-06-16 4 AS $98.50 $1,056,004 D/D (10,686) 130,637 -3%     
   Schaeffer Orlov S Nicole Chief People Strategy Officer   •       –      –    2025-06-11 4 AS $91.68 $9,264,345 D/D (99,172) 89,407 0%     
   Schaeffer Orlov S Nicole Chief People Strategy Officer   •       –      –    2025-06-11 4 OE $13.91 $973,700 D/D 70,000 188,579     -
   Flammer Martina M.d. Chief Medical Officer   •       –      –    2025-06-11 4 AS $94.50 $1,835,474 D/D (19,423) 83,111 0%     
   Flammer Martina M.d. Chief Medical Officer   •       –      –    2025-06-11 4 OE $17.07 $331,551 D/D 19,423 102,534     -
   Bonstein Sara Chief Financial Officer   •       –      –    2025-06-10 4 AS $87.12 $5,148,024 D/D (57,766) 103,412 8%     
   Bonstein Sara Chief Financial Officer   •       –      –    2025-06-10 4 OE $17.07 $862,884 D/D 47,890 161,178     -
   Schaeffer Orlov S Nicole Chief People Strategy Officer   •       –      –    2025-06-10 4 AS $88.64 $3,394,912 D/D (38,300) 118,579 8%     
   Schaeffer Orlov S Nicole Chief People Strategy Officer   •       –      –    2025-06-10 4 OE $17.16 $657,228 D/D 38,300 156,879     -
   Flammer Martina M.d. Chief Medical Officer   •       –      –    2025-06-10 4 AS $88.64 $2,281,594 D/D (25,740) 83,111 8%     
   Flammer Martina M.d. Chief Medical Officer   •       –      –    2025-06-10 4 OE $26.46 $681,080 D/D 25,740 108,851     -
   Smith Michael Alexander Chief Legal Officer   •       –      –    2025-06-05 4 AS $73.50 $138,107 D/D (1,879) 67,718 35%     
   Mcgirr David W J Director   –       •      –    2025-06-04 4 AS $73.27 $219,810 D/D (3,000) 97,723 33%     
   Mcgirr David W J Director   –       •      –    2025-06-03 4 AS $71.30 $231,725 D/D (3,250) 100,723 34%     
   Adsett Roger Chief Operating Officer   •       –      –    2025-06-03 4 S $71.50 $132,990 D/D (1,860) 141,323 -34%     
   Smith Michael Alexander Chief Legal Officer   •       –      –    2025-06-03 4 S $71.50 $103,532 D/D (1,448) 69,597 -34%     
  595 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 24
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2025 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us